The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular CarcinomaShuji Sumie, Michio Sata, Osamu Nakashima et al.|Annals of Surgical Oncology|2013Cited by 201
Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasisHajime Aino, Michio Sata, Shuji Sumie et al.|Molecular and Clinical Oncology|2014Cited by 84
Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective StudyShigeo Shimose, Takuji Torimura, Hideki Iwamoto et al.|Cancers|2020Cited by 78
Effects of in‐hospital exercise on liver function, physical ability, and muscle mass during treatment of hepatoma in patients with chronic liver diseaseShunji Koya, Takuji Torimura, Yoshiko Matsushita et al.|Hepatology Research|2016Cited by 71
Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse EventsHideki Iwamoto, Takuji Torimura, Hiroyuki Suzuki et al.|Cancers|2020Cited by 68